首页> 外文期刊>The Lancet >Septic shock.
【24h】

Septic shock.

机译:败血性休克。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Septic shock, the most severe complication of sepsis, is a deadly disease. In recent years, exciting advances have been made in the understanding of its pathophysiology and treatment. Pathogens, via their microbial-associated molecular patterns, trigger sequential intracellular events in immune cells, epithelium, endothelium, and the neuroendocrine system. Proinflammatory mediators that contribute to eradication of invading microorganisms are produced, and anti-inflammatory mediators control this response. The inflammatory response leads to damage to host tissue, and the anti-inflammatory response causes leucocyte reprogramming and changes in immune status. The time-window for interventions is short, and treatment must promptly control the source of infection and restore haemodynamic homoeostasis. Further research is needed to establish which fluids and vasopressors are best. Some patients with septic shock might benefit from drugs such as corticosteroids or activated protein C. Other therapeutic strategies are under investigation, including those that target late proinflammatory mediators, endothelium, or the neuroendocrine system.
机译:败血性休克是败血症最严重的并发症,是一种致命的疾病。近年来,在了解其病理生理学和治疗方面取得了令人兴奋的进展。病原体通过其微生物相关的分子模式触发免疫细胞,上皮,内皮和神经内分泌系统中的顺序性细胞内事件。产生有助于消灭入侵微生物的促炎介质,而抗炎介质控制该反应。炎症反应导致对宿主组织的损害,而抗炎反应导致白细胞重编程和免疫状态改变。干预的时间很短,治疗必须及时控制感染源并恢复血流动力学平衡。需要进一步的研究以确定哪种液体和升压药是最好的。一些感染性休克的患者可能会受益于诸如皮质类固醇或活化蛋白C之类的药物。其他治疗策略正在研究中,包括针对晚期促炎性介质,内皮或神经内分泌系统的那些。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号